Go to the list of all blogs
published in Blogs
Sep 25, 2026
Strive (ASST) Climbs +37% as Bitcoin Treasury Builds Momentum

Strive (ASST) Climbs +37% as Bitcoin Treasury Builds Momentum

Key Takeaways

  • ASST climbed roughly 37% over the trailing 30 days, rising from about $21.50 to near $29.50, as Strive accelerated its Bitcoin treasury accumulation.
  • Strive added approximately 3,200 BTC across three disclosed purchases during the period, lifting its holdings to 26,355 BTC and a top-five ranking among public corporate Bitcoin holders.
  • The company's SATA perpetual preferred stock crossed roughly $1 billion in notional outstanding, funding purchases without relying on debt or dilutive common-equity issuance at depressed prices.
  • A rebound in Bitcoin above $85,000, a new 2x leveraged ETF tied to ASST, and an analyst price-target increase amplified investor attention on the name.
  • TD Cowen raised its ASST price target from $32 to $44, citing faster-than-expected growth in Bitcoin held per share.

Strive (ASST) Company Snapshot

Strive, Inc. (NASDAQ: ASST), formerly Asset Entities Inc., is a Dallas-based asset management and Bitcoin treasury company. The firm was founded by Vivek Ramaswamy and is led by Chief Executive Officer Matt Cole. Strive went public through a reverse merger in September 2025 and has since transformed from a conventional asset manager into one of the most aggressive corporate Bitcoin accumulators in the public markets.

The business is divided into two segments: an asset management operation that generates revenue from investment advisory fees and index-based fund products, and a corporate segment centered on its Bitcoin treasury. In practice, investors now primarily value ASST as a Bitcoin treasury company, where the size and growth of the BTC reserve, the cost basis of purchases, and the firm's financing structure drive the share price more than traditional earnings metrics. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

ASST Stock Moves: +37% Over 30 Days and Stronger Quarterly Gains

Over the trailing 30 days, ASST advanced roughly 37%, moving from a close of about $21.50 in late August to around $29.50. The move was not linear; the stock consolidated near the $21–24 range through late August before breaking higher in September alongside Bitcoin's rally.

The quarterly picture is even more pronounced. In late June, ASST traded near $11–12, meaning the stock has more than doubled over the trailing three months. This multi-month advance reflects a broad re-rating of the Bitcoin treasury complex rather than a single isolated catalyst, though the pace of accumulation has clearly intensified into September. From what I see, the price action aligns closely with broader sector momentum.

Key Drivers Behind the Recent 30-Day Advance

The dominant driver has been Strive's relentless Bitcoin accumulation. During the period, the company disclosed a 1,375 BTC purchase for roughly $109 million (August 31–September 4), a 469 BTC purchase for about $36.6 million (September 8–11), and a 1,355 BTC purchase for approximately $107.7 million (September 14–18). Combined, these lifted the treasury from about 23,000 BTC to 26,355 BTC.

The funding engine behind this buying is SATA, Strive's Variable Rate Series A Perpetual Preferred Stock, which pays a variable annualized dividend of roughly 13% on a daily basis. SATA's notional outstanding surpassed $1 billion, and warrant exercises added approximately $21.2 million in gross proceeds, giving the company a continuous capital pipeline with what management describes as a debt-free balance sheet. I’m watching this closely because the structure avoids dilution at lower prices.

Supporting the move, Bitcoin crossed above $85,000 in late September for the first time since January, directly lifting the value of Strive's reserve. TD Cowen raised its ASST price target from $32 to $44, citing stronger-than-expected Bitcoin-per-share growth. The launch of a 2x leveraged single-stock ETF (ASSX) by REX Shares and Tuttle Capital Management also brought fresh retail and trading flows into the name, while Strive's market capitalization surpassed that of rival treasury firm Metaplanet.

Quarterly Performance Context and Sector Re-Rating

The quarterly advance reflects a broader re-rating of the Bitcoin treasury sector as a distinct asset class. Strive has positioned itself as a financing-driven accumulator, using perpetual preferred equity rather than the convertible-debt playbook popularized by Strategy (MSTR). This structure has allowed Strive to scale its holdings rapidly while keeping leverage at zero, a combination investors have rewarded with a premium valuation relative to pure-accumulation peers such as MARA.

The firm's rise to the fifth-largest public Bitcoin holder, its weekly cadence of disclosed purchases, and management's stated ambition to climb further up the rankings have sustained momentum through the quarter, even as the broader Bitcoin treasury complex has otherwise experienced a challenging 2026.

Factors to Monitor Going Forward

Several factors will shape ASST's path going forward. First, Strive's weekly Form 8-K Bitcoin disclosures remain the most direct catalyst, as each purchase changes the company's per-share Bitcoin exposure. Second, the direction of Bitcoin itself is critical, given that the reserve's mark-to-market value drives net asset value and sentiment; macroeconomic conditions, Federal Reserve policy, and ETF flows are all relevant inputs. Third, SATA's ability to continue trading at or above its $100 par value determines whether the at-the-market funding engine keeps running, while ongoing warrant exercises could create additional share supply. Fourth, analysts will likely update price targets as the accumulation pace and Bitcoin-per-share growth evolve. Finally, trading flows tied to the leveraged ASSX ETF and broader sector rotation among Bitcoin treasury stocks may add to near-term volatility. These are factors to monitor, not predictions of future performance. One thing that stands out is how the weekly disclosures keep providing fresh data points.

Using Tickeron Tools in My Research

In my own work, I regularly consult Tickeron’s AI Daily Buy/Sell Signals to cross-check momentum across names like ASST. The platform’s automated signals help me quickly compare price action against historical patterns without replacing my fundamental review. It has become a useful supplement when evaluating treasury-focused stocks amid volatile market conditions.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: ASST

ASST sees its 50-day moving average cross bullishly above its 200-day moving average

The 50-day moving average for ASST moved above the 200-day moving average on September 04, 2026. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

Following a +2.73% 3-day Advance, the price is estimated to grow further. Considering data from situations where ASST advanced for three days, in 133 of 154 cases, the price rose further within the following month. The odds of a continued upward trend are 86%.

The Aroon Indicator entered an Uptrend today. In 59 of 69 cases where ASST Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 86%.

Bearish Trend Analysis

The 10-day RSI Indicator for ASST moved out of overbought territory on September 25, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 19 similar instances where the indicator moved out of overbought territory. In 19 of the 19 cases, the stock moved lower in the following days. This puts the odds of a move lower at 90%.

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 20 of 21 cases where ASST's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 90%.

The Momentum Indicator moved below the 0 level on October 02, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on ASST as a result. In 53 of 62 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 85%.

The Moving Average Convergence Divergence Histogram (MACD) for ASST turned negative on September 22, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 24 similar instances when the indicator turned negative. In 23 of the 24 cases the stock turned lower in the days that followed. This puts the odds of success at 90%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ASST declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is 34 (best 1 - 100 worst), indicating steady price growth. ASST’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 99 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.382) is normal, around the industry mean (3.242). P/E Ratio (0.000) is within average values for comparable stocks, (26.802). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.341). ASST has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.081). ASST's P/S Ratio (113.636) is very high in comparison to the industry average of (15.853).

The Tickeron PE Growth Rating for this company is 100 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ASST’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 82, placing this stock worse than average.

Notable companies

The most notable companies in this group are Ares Capital Corp (NASDAQ:ARCC), WisdomTree (NYSE:WT), AMTD IDEA Group (NYSE:AMTD).

Industry description

Investment Managers manage financial assets and other investments of clients. Management includes designing a short- or long-term strategy for buying/holding and selling of portfolio holdings. It can also include tax services and other aspects of financial planning as well. While it is perceived that the industry is faced with growing competition from robo-advisors/digital platforms and passive/ index-tracking funds, many investors still find value in actively managed in-person services that investment management companies often emphasize on. At the same time, many wealth managers are also incorporating digital initiatives/low cost options in addition to their in-person customized services. Their main sources of revenues are fees as a percentage of assets under management, in addition to a certain portion of clients’ gains from asset appreciation. BlackRock, Inc., Blackstone Group Inc and Brookfield Asset Management are some of the major investment management companies.

Market Cap

The average market capitalization across the Investment Managers Industry is 8.63B. The market cap for tickers in the group ranges from 57 to 165.9B. BLK holds the highest valuation in this group at 165.9B. The lowest valued company is RSERF at 57.

High and low price notable news

The average weekly price growth across all stocks in the Investment Managers Industry was 0%. For the same Industry, the average monthly price growth was 3%, and the average quarterly price growth was 8%. SDEV experienced the highest price growth at 402%, while INV experienced the biggest fall at -31%.

Volume

The average weekly volume growth across all stocks in the Investment Managers Industry was 88%. For the same stocks of the Industry, the average monthly volume growth was 168% and the average quarterly volume growth was 45%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 30
P/E Growth Rating: 53
Price Growth Rating: 55
SMR Rating: 67
Profit Risk Rating: 81
Seasonality Score: 37 (-100 ... +100)
View a ticker or compare two or three
ASST
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Industry InvestmentManagers

Industry
N/A
Address
200 Crescent Court
Phone
+1 855 427-7360
Employees
28
Web
https://www.strive.com
Interact to see
Advertisement
AMZN stock declined approximately -4% over the past 30 days amid concerns over elevated AI-driven capital expenditures pressuring margins. Over the past quarter, the stock fell around -13%, reflecting post-earnings selloff and broader tech sector volatility. Major drivers include surging AWS demand offset by high capex forecasts of up to $200 billion for 2026, macroeconomic pressures like trade policy risks, and geopolitical tensions impacting sentiment.
Taiwan Semiconductor Manufacturing Company Limited (TSM) ADRs rose 4.68% in the most recent completed session, climbing from a prior close of $316.50 to $331.32. The move comes after a brief two‑day pullback and reflects renewed buying interest as investors refocus on TSMC’s role at the center of the AI chip supply chain.
APA Corporation delivered strong Q4 2025 results, beating EPS estimates with $0.91 adjusted earnings per share and $1.0 billion full-year free cash flow. Stock surged over 45% in recent weeks amid rising oil prices and geopolitical tensions, hitting 52-week highs near $45.66. 2026 capital plan set at $2.1 billion, targeting cost savings run-rate of $450 million and flat U.S. oil production.
I've been watching DVN closely in recent sessions, and it's held up well amid a broader energy sector rally driven by elevated oil prices. The stock has outperformed broader indices, which speaks to investor confidence in its strong positioning in U.S. shale plays, especially the Permian Basin. Volatility remains a factor with macroeconomic pressures and commodity swings, but the company's emphasis on capital discipline and returns to shareholders has encouraged steady buying. Trading volumes have increased, indicating growing interest as DVN manages merger developments and production shifts in this market cycle.
LLY stock declined -13% over the past 30 days amid concerns over obesity drug pricing pressures and competition from NVO. Over the past quarter, the stock fell around -17%, despite strong Q4 2025 earnings driven by Mounjaro and Zepbound volume growth. Bearish analyst notes on market saturation and potential price wars outweighed positive trial data for next-gen drugs like retatrutide.
I've been keeping a close eye on EOG Resources (EOG), and it's clear the stock has held up well through recent volatility. Year-to-date gains are approaching 38%, which stands out against the broader energy sector. The shares are trading above key moving averages, supported by investor confidence in the company's low-cost production and diversified multi-basin portfolio. Elevated crude oil prices have provided a tailwind, even as macroeconomic pressures have led to occasional dips. With a solid balance sheet and reliable free cash flow, EOG looks well-positioned in this market cycle.
Diamondback Energy (FANG), a leading independent oil and natural gas producer focused on the Permian Basin, has shown impressive resilience lately. In my view, the stock's climb of around 16% over recent weeks stands out, especially as it has traded near its 52-week high while outperforming key energy indices and the broader market. This momentum seems driven by favorable oil price dynamics, positive analyst revisions, and the company's operational efficiency paired with its exposure to rising crude benchmarks. Even with broader market fluctuations, FANG's robust cash flows and recent dividend enhancements continue to draw interest from both momentum traders and long-term investors.
MTDR stock surged +20% over the past 30 days, driven by escalating oil prices amid Iran conflict disruptions and strong Q4 2025 earnings beat. Over the past quarter, shares climbed +53%, fueled by record production, positive 2026 guidance, and analyst price target upgrades.
I've been watching OXY closely, and it's clear the stock has shown robust strength in recent trading sessions. It's advanced amid heightened oil prices driven by global supply concerns, outperforming broader indices. This reflects investor confidence in its Permian Basin dominance and operational resilience. Trading near the upper end of its 52-week range, OXY benefits from elevated crude realizations that enhance margins in its core upstream business. While sector peers have also gained, the company's focus on cost efficiencies and debt reduction positions it favorably in the latest market cycle. Heightened volume underscores sustained interest as macroeconomic pressures test energy equities.
I've been watching Antero Resources (AR) closely through recent trading sessions, where the stock has handled volatility well amid natural gas price swings and broader energy sector shifts. It's trading near the upper end of its 52-week range, with year-to-date gains exceeding +25%. From what I see, this reflects investor confidence in the company's growing Marcellus footprint and its disciplined approach to capital allocation. The upward momentum ties directly to positive analyst revisions and a solid production outlook. Macro factors like LNG export demand and data center growth continue to support sentiment in the natural gas space.
I've been tracking Magnolia Oil & Gas (MGY) closely, and it's clear the stock has put in a strong showing lately. It's trading near the top of its 52-week range, buoyed by positive dynamics in the energy sector. From what I see, investor interest in oil and gas producers like MGY is picking up, thanks to improved production efficiency and a focus on capital discipline. The shares have held up well, with a PE ratio around 18 and a dividend yield close to 2%. Sector-wide support from stronger commodity prices has helped drive this momentum, placing MGY in a solid spot among exploration and production peers. Trading volume reflects this engagement, aligning with the broader uptick in activity.
PR stock surged +18% over the past 30 days, driven by investment-grade credit rating upgrades from S&P and Fitch, analyst price target increases, and rising oil prices. Over the past quarter, shares climbed +55%, fueled by record Q4 2025 production, strong earnings beat, dividend hike, and robust operational efficiencies. Key factors include credit upgrades enhancing financial flexibility, positive analyst sentiment with multiple buy ratings, and favorable sector trends from higher crude oil realizations.
RRC stock rose +11% over the past 30 days, driven by strong Q4 2025 earnings beat, dividend hike, and positive 2026 guidance. Over the past quarter, shares gained +31%, reflecting robust free cash flow generation and operational efficiency in the Appalachian Basin.
From what I see, Exxon Mobil Corporation (XOM) stands out as one of the world's largest integrated energy companies, involved in the exploration, production, refining, and marketing of oil, natural gas, and petrochemicals. Its business model covers the full hydrocarbon value chain, from upstream production to downstream refining and chemicals, which offers diversification against commodity price swings. In the oil and gas industry, Exxon Mobil maintains a leading position thanks to its vast reserves, especially in high-return areas like the Permian Basin in the U.S. and offshore Guyana. The company's strong fundamentals—record production volumes and ongoing cost savings—have supported recent stock strength, as higher oil prices boost upstream earnings and refining profits from wider margins.
I've been watching TMV closely through recent trading sessions, where it's handled heightened volatility linked to swings in long-term Treasury yields. This ETF delivers -3x the inverse daily performance of 20+ year U.S. Treasuries, and it's held up well amid pressures in the broader fixed income space. From what I see, rising energy costs and macroeconomic uncertainties have driven yields higher, which plays right into TMV's strengths. The fund is trading within its 52-week range, backed by strong liquidity and substantial daily volume—making it suitable for active traders looking to position around rate-sensitive moves. Recent market cycles really underscore TMV's value in tactical strategies tied to bond market shifts.
From what I see, Constellation Energy stands out as the largest producer of carbon-free energy in the U.S., with the nation's biggest nuclear fleet boasting over 21 GW of capacity—that's roughly 10% of U.S. clean energy output. This scale delivers unmatched reliability for baseload power, which is exactly what hyperscalers like Microsoft and Meta need for their 24/7 carbon-free electricity demands to power AI data centers. Post-Calpine acquisition, the company's ~55 GW fleet now spans nuclear, natural gas, and renewables, providing geographic diversity across key markets like PJM and ERCOT.
In my view, Karman Holdings Inc. (KRMN) really stands out in the aerospace and defense sector with its focus on mission-critical subsystems, including payload protection and deployment systems, aerodynamic interstage systems, and propulsion systems. The company serves high-growth markets like hypersonics, strategic missile defense, tactical missiles, and space launch, benefiting from proprietary engineering and manufacturing capabilities that enable rapid development for prime contractors.
As one of the top three global players in the semiconductor memory market, Micron Technology holds about 22% share in DRAM and is building a stronger foothold in NAND flash storage. What stands out to me is the company's leadership in high-bandwidth memory (HBM), which is essential for AI accelerators. By early 2026, Micron has secured around 21% market share here, thanks to its efficient 12-high and 36GB HBM4 stacks that use 30% less power than competitors.
I've been following Viridian Therapeutics ($VRDN) closely as it carves out a strong position in the thyroid eye disease (TED) market—a rare autoimmune disorder that causes orbital inflammation, proptosis, diplopia, and even vision loss in severe cases. The company draws on its antibody discovery and protein engineering expertise to create differentiated IGF-1R inhibitors, building on the validated pathway pioneered by Tepezza (teprotumumab). What stands out to me is how veligrotug diverges from Tepezza's frequent IV infusions: it offers a more convenient 12-week course with robust efficacy demonstrated in Phase 3 trials for both active and chronic TED, which could help it gain market share through better patient tolerability.
I've been following Applied Optoelectronics, Inc. (AAOI) closely as it designs, manufactures, and sells fiber-optic networking products, including optical transceivers, lasers, and components. These serve internet data centers, cable television (CATV), telecom, and fiber-to-the-home (FTTH) markets. What stands out is the company's vertically integrated model—from chip fabrication using proprietary molecular beam epitaxy (MBE) lasers to module assembly—which gives it an edge in rapid innovation and cost control.